You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 138 No. 11, November 1978 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (20)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Cyclophosphamide-Induced Urticaria

Occurrence in a Patient With No Cross-Sensitivity to Chlorambucil

Allan N. Krutchik, MD; Aman U. Buzdar, MD; Charles K. Tashima, MD

Arch Intern Med. 1978;138(11):1725-1726.


Abstract



A patient receiving adjuvant chemoimmunotherapy for breast carcinoma developed urticaria secondary to cyclophosphamide, one of the drugs of the chemotherapy regimen. Chlorambucil, another alkylating agent, was substituted with no cross-sensitivity noted.

(Arch Intern Med 138:1725-1726, 1978)



Author Affiliations



From the Medical Breast Service, Department of Medicine, University of Texas System Cancer Center, M. D. Anderson Hospital and Tumor Institute, Houston.


Footnotes



Accepted for publication June 7, 1978.

Reprint requests to Department of Medicine, M. D. Anderson Hospital and Tumor Institute, 6723 Bertner Ave, Houston, TX 77030 (Dr Buzdar).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cyclophosphamide type I hypersensitivity in systemic lupus erythematosus
Thong et al.
Lupus 2002;11:127-129.
ABSTRACT  

Hypersensitivity Reactions to Cancer Chemotherapeutic Agents
WEISS and BRUNO
ANN INTERN MED 1981;94:66-72.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1978 American Medical Association. All Rights Reserved.